陈红丹, 林献丹, 刘丽琳, 李万仓. 温州市瓯海区2008—2013年预防接种后过敏性皮疹监测分析[J]. 上海预防医学, 2015, 27(6): 321-323.
引用本文: 陈红丹, 林献丹, 刘丽琳, 李万仓. 温州市瓯海区2008—2013年预防接种后过敏性皮疹监测分析[J]. 上海预防医学, 2015, 27(6): 321-323.
CHEN Hong-dan, LIN Xian-dan, LIU Li-lin, LI Wan-cang. Surveillance analysis on anaphylactic rash after immunization in Ouhai District of Wenzhou City,2008-2013[J]. Shanghai Journal of Preventive Medicine, 2015, 27(6): 321-323.
Citation: CHEN Hong-dan, LIN Xian-dan, LIU Li-lin, LI Wan-cang. Surveillance analysis on anaphylactic rash after immunization in Ouhai District of Wenzhou City,2008-2013[J]. Shanghai Journal of Preventive Medicine, 2015, 27(6): 321-323.

温州市瓯海区2008—2013年预防接种后过敏性皮疹监测分析

Surveillance analysis on anaphylactic rash after immunization in Ouhai District of Wenzhou City,2008-2013

  • 摘要: 目的分析温州市瓯海区2008-2013年预防接种后过敏性皮疹的发生特征。方法收集温州市瓯海区2008-2013年疑似预防接种异常反应(AEFI)信息管理系统中诊断为过敏性皮疹的个案数据,采用描述性流行病学方法进行分析。结果瓯海区2008-2013年共报告过敏性皮疹111例,过敏性皮疹报告发生率为3.58/10万剂。男女性别比为1.27:1;<1岁儿童占65.77%;不伴发热的占75.68%;第三季度报告数占41.44%;主要发生在接种疫苗后24 h内(81.08%)。报告病例数居前三位的是麻-风疫苗(35.14%)、无细胞百白破疫苗(18.92%)、甲型H1N1流感疫苗(5.41%);报告发生率居前三位的是7价肺炎疫苗(115.85/10万剂)、麻-风疫苗(29.33/10万剂)和甲型H1N1流感疫苗(13.07/10万剂)。结论需加强过敏性皮疹的鉴别诊断,虽然大部分疫苗过敏性皮疹报告发生率均在预期范围内,但仍需加强监测分析,尤其要关注发生率相对较高的疫苗。

     

    Abstract: Objective To analyze the characteristics of anaphylactic rash after vaccination in Ouhai District of Wenzhou City during 2008-2013. Methods Data on anaphylactic rash cases reported during 2008-2013 were collected through the national AEFI information management system.And descriptive epidemiologic methodology was used in this study. Results A total of 111 anaphylactic rash cases were reported in Ouhai District during 2008-2013,the reported incidence rate of anaphylactic rash were 3.58 per million doses. The ratio of male-female was 1.27:1. Cases of ≤ 1 year old accounted for 65.77%. Those without fever accounted for 75.68%. The number of the reports for the third quarter of the year accounted for 41.44% of the total. The cases of anaphylactic rash mostly occurred within 24 h after immunization(81.08%).The top three vaccines reported in occurrence of rash were measles and rubella attenuated live vaccine(35.14%), diphtheria, tetanus and acellular pertussis combined vaccine(18.92%),and A(H1N1)influenza vaccine(5.41%).The reported rates for the top three vaccines were 115.85,29.33,13.07 per million doses for 7-valent pneumococcal polysaccharide conjugate vaccine,measles and rubella combined attenuated live vaccine, A(H1N1) influenza vaccine,respectively. Conclusion Differential diagnosis of anaphylactic rashes needs to be more stressed.Most anaphylactic rash were reported in the expected range,but still monitoring analysis on incidence of allergic rash should be enhanced.Vaccines with higher incidence of rash reported should be further studied and analyzed.

     

/

返回文章
返回